2018 American Transplant Congress

Sunday, June 3, 2018

6:00pm-7:00pm

A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study

F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.

Poster Session B: Kidney Psychosocial  •  Hall 4EF

6:00pm-7:00pm

A New Reality: Virtual Crossmatch Can Be Used Successfully as Pre-Transplant Compatibility Testing for Most Deceased Donor Transplants at a High Volume Center

R. Rajalingam,¹ D. Gae,¹ Z. Laszik,² G. Roll,³ M. Tavakol,³ C. Freise,³ D. Adey,⁴ A. Webber,⁴ D. Dobi,² K. Cunniffe,¹ G. da Gente,¹ N. Ascher,³ P. Stock,³ J. Roberts.³

Poster Session B: Kidney Deceased Donor Allocation  •  Hall 4EF

6:00pm-7:00pm

A Novel Endothelial Cell Based Complement Dependent Cytotoxicity Test in Kidney Transplantation

R. Lammerts,¹ J. van den Born,¹ W. Dam,¹ M. Seelen,¹ B. Hepkema,² B. Kroesen,² M. Daha,¹ R. Pol,³ S. Berger,¹ On behalf of the COMBAT Consortium.¹

Poster Session B: Endothelial Cell Biology  •  Hall 4EF

6:00pm-7:00pm

A Population Based Study of Incidence of Post Kidney Transplant Malignancies

D. Sexton,¹ J. O'Neill,² P. O'Kelly,¹ S. Murray,¹ S. Deady,³ E. O'Leary,³ P. Morris,⁴ P. Conlon.¹

Poster Session B: PTLD/Malignancies: All Topics  •  Hall 4EF

6:00pm-7:00pm

A Proteomic Analysis of Kidneys Subjected to Normothermic Ex Vivo Kidney Perfusion (NEVKP) Demonstrates That Metabolism is an Important Determinant of Kidney Function Following Warm Ischemia

A. Konvalinka,^1,4 T. Tokar,² S. Reid,⁴ P. Urbanellis,⁴ M. Hamar,⁴ M. Kaths,⁴ I. Jurisica,² L. Robinson,^4,3 M. Selzner.^4,5

Poster Session B: Acute and Chronic Graft Injury  •  Hall 4EF

6:00pm-7:00pm

A Protocol for the Management of Alemtuzumab Induced Leukopenia in Kidney Transplant Recipients

S. Hammad, B. Ravichandran, M. Crist, B. Masters.

Poster Session B: Kidney Immunosuppression: Induction Therapy  •  Hall 4EF

6:00pm-7:00pm

A Research-Informed Framework for a Medication Adherence Intervention to Support Transition of Adolescent Kidney Recipients to Independent Medication-Taking

T. Irizarry,¹ A. DeVito Dabbs,¹ M. Dew,¹ B. Foster.²

Poster Session B: Kidney: Pediatrics  •  Hall 4EF

6:00pm-7:00pm

A Review of Pediatric Drug Development Programs and FDA Labeling for Immunosuppressive Drugs in Organ Transplant Patients

G. Burckart,¹ M. Cavaillé-Coll,² A. Duong,³ L. Hothem,⁴ R. Albrecht.²

Poster Session B: Kidney: Pediatrics  •  Hall 4EF

6:00pm-7:00pm

A Theoretical Framework to Explain Factors That Impact Completion of the Medical Evaluation Process for African American (AA) End-Stage Renal Disease (ESRD) Patient

C. Nonterah,¹ H. Gardiner,² D. Vavra.¹

Poster Session B: Kidney Psychosocial  •  Hall 4EF

6:00pm-7:00pm

ABO Incompatible Deceased Donor Kidney Transplantation – Time to Remove the Barrier

J. Melancon,¹ M. Nayebpour,² K. Mahendran,¹ H. Spivak,¹ N. Koizumi.²

Poster Session B: Kidney Deceased Donor Allocation  •  Hall 4EF